In this article the author sought to highlight the most remarkable findings concerning headache secondary to COVID-19, specifically focusing on epidemiology, characteristics, pathophysiology, and treatments.
In this study the authors retrospectively studied 4742 patients with acute infectious respiratory disease (AIRD); 2579 were diagnosed to have COVID-19 and treated with heparin, whereas 2163 had other causes of AIRD.
One year on from the onset of the COVID-19 pandemic, the authors aimed to summarise the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality.
Study to define the prevalence of neurological conditions among hospitalized patients with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test in geographically diverse multinational populations.
In this study, the authors built on their previous publication using a new, larger cohort to investigate whether they could reproduce previous findings while addressing some of the prior study's limitations.